View in EDS HTML Full Text PDF Full Text

The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety.

Saved in:
Bibliographic Details
Title: The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety.
Authors: Leonard, Charles E.1 (AUTHOR) celeonar@pennmedicine.upenn.edu, Brensinger, Colleen M.1 (AUTHOR), Dawwas, Ghadeer K.1 (AUTHOR), Deo, Rajat1,2 (AUTHOR), Bilker, Warren B.1 (AUTHOR), Soprano, Samantha E.1 (AUTHOR), Dhopeshwarkar, Neil1 (AUTHOR), Flory, James H.1,3 (AUTHOR), Bloomgarden, Zachary T.4 (AUTHOR), Gagne, Joshua J.5 (AUTHOR), Aquilante, Christina L.6 (AUTHOR), Kimmel, Stephen E.1,2 (AUTHOR), Hennessy, Sean1,7 (AUTHOR)
Source: Cardiovascular Diabetology. 2/25/2020, Vol. 19 Issue 1, p1-11. 11p. 2 Charts, 2 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14752840
DOI:10.1186/s12933-020-00999-5